UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 134

Sortiert nach

Multicenter Phase II Study of Neoadjuvant Lapatinib and Trastuzumab With Hormonal Therapy and Without Chemotherapy in Patients With Human Epidermal Growth Factor Receptor 2–Overexpressing Breast Cancer: TBCRC 006

Journal of clinical oncology, 2013-05, Vol.31 (14), p.1726-1731

2013

Link zum Volltext

Verfügbarkeit prüfen

STAT3 Signaling Is Activated Preferentially in Tumor‐Initiating Cells in Claudin‐Low Models of Human Breast Cancer

Stem cells (Dayton, Ohio), 2014-10, Vol.32 (10), p.2571-2582

2014

Link zum Volltext

Verfügbarkeit prüfen

Loss of Phosphatase and Tensin Homolog or Phosphoinositol-3 Kinase Activation and Response to Trastuzumab or Lapatinib in Human Epidermal Growth Factor Receptor 2–Overexpressing Locally Advanced Breast Cancers

Journal of clinical oncology, 2011-01, Vol.29 (2), p.166-173

2011

Link zum Volltext

Verfügbarkeit prüfen

Insulin-Like Growth Factor-I Activates Gene Transcription Programs Strongly Associated With Poor Breast Cancer Prognosis

Journal of clinical oncology, 2008-09, Vol.26 (25), p.4078-4085

2008

Link zum Volltext

Verfügbarkeit prüfen

Modernizing Eligibility Criteria for Molecularly Driven Trials

Journal of clinical oncology, 2015-09, Vol.33 (25), p.2815-2820

2015

Link zum Volltext

Verfügbarkeit prüfen

Making Sense of Clinical Trial Data: Is Inverse Probability of Censoring Weighted Analysis the Answer to Crossover Bias?

Journal of clinical oncology, 2012-02, Vol.30 (4), p.453-458

2012

Link zum Volltext

Verfügbarkeit prüfen

The HOXB13:IL17BR Expression Index Is a Prognostic Factor in Early-Stage Breast Cancer

Journal of clinical oncology, 2006-10, Vol.24 (28), p.4611-4619

2006

Link zum Volltext

Verfügbarkeit prüfen

A fully Bayesian latent variable model for integrative clustering analysis of multi-type omics data

Biostatistics (Oxford, England), 2018-01, Vol.19 (1), p.71-86

2018

Link zum Volltext

Verfügbarkeit prüfen

Analysis of phosphatases in ER-negative breast cancers identifies DUSP4 as a critical regulator of growth and invasion

Breast cancer research and treatment, 2016-08, Vol.158 (3), p.441-454

2016

Link zum Volltext

Verfügbarkeit prüfen

Cyclopamine inhibition of human breast cancer cell growth independent of Smoothened (Smo)

Breast cancer research and treatment, 2009-06, Vol.115 (3), p.505-521

2009

Link zum Volltext

Verfügbarkeit prüfen

Neoadjuvant Trastuzumab Induces Apoptosis in Primary Breast Cancers

Journal of clinical oncology, 2005-04, Vol.23 (11), p.2460-2468

2005

Link zum Volltext

Verfügbarkeit prüfen

BRCAPRO Validation, Sensitivity of Genetic Testing of BRCA1/BRCA2, and Prevalence of Other Breast Cancer Susceptibility Genes

Journal of clinical oncology, 2002-06, Vol.20 (11), p.2701-2712

2002

Link zum Volltext

Verfügbarkeit prüfen

Gene expression patterns in formalin-fixed, paraffin-embedded core biopsies predict docetaxel chemosensitivity in breast cancer patients

Breast cancer research and treatment, 2008-03, Vol.108 (2), p.233-240

2008

Link zum Volltext

Verfügbarkeit prüfen

Identification of Murine Uterine Genes Regulated in a Ligand-Dependent Manner by the Progesterone Receptor

Endocrinology (Philadelphia), 2005-08, Vol.146 (8), p.3490-3505

2005

Link zum Volltext

Verfügbarkeit prüfen

Patterns of Resistance and Incomplete Response to Docetaxel by Gene Expression Profiling in Breast Cancer Patients

Journal of clinical oncology, 2005-02, Vol.23 (6), p.1169-1177

2005

Link zum Volltext

Verfügbarkeit prüfen

Amplification and over-expression of MAP3K3 gene in human breast cancer promotes formation and survival of breast cancer cells

The Journal of pathology, 2014-01, Vol.232 (1), p.75-86

2014

Link zum Volltext

Verfügbarkeit prüfen

Intrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy

JNCI : Journal of the National Cancer Institute, 2008-05, Vol.100 (9), p.672-679

2008

Link zum Volltext

Verfügbarkeit prüfen

Estrogen and insulin-like growth factor-I (IGF-I) independently down-regulate critical repressors of breast cancer growth

Breast cancer research and treatment, 2012-02, Vol.132 (1), p.61-73

2012

Link zum Volltext

Verfügbarkeit prüfen

Enhancement of Insulin-Like Growth Factor Signaling in Human Breast Cancer: Estrogen Regulation of Insulin Receptor Substrate-1 Expression in Vitro and in Vivo

Molecular endocrinology (Baltimore, Md.), 1999-05, Vol.13 (5), p.787-796

1999

Link zum Volltext

Verfügbarkeit prüfen

Association of Surgery With Improved Survival in Stage IV Breast Cancer Patients

Annals of surgery, 2008-05, Vol.247 (5), p.732-738

2008

Link zum Volltext

Verfügbarkeit prüfen

Thermal enhancement with optically activated gold nanoshells sensitizes breast cancer stem cells to radiation therapy

Science translational medicine, 2010-10, Vol.2 (55), p.55ra79

2010

Link zum Volltext

Verfügbarkeit prüfen

Transcriptional Profiling of Mammary Gland Side Population Cells

Stem cells (Dayton, Ohio), 2006-04, Vol.24 (4), p.1065-1074

2006

Link zum Volltext

Verfügbarkeit prüfen

Hazard rates of recurrence following diagnosis of primary breast cancer

Breast cancer research and treatment, 2005, Vol.89 (2), p.173-178

2005

Link zum Volltext

Verfügbarkeit prüfen

Low PTEN levels and PIK3CA mutations predict resistance to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2 over-expressing breast cancer

Breast cancer research and treatment, 2018-02, Vol.167 (3), p.731-740

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 134

Suche als RSS-Feed

Aktive Filter

KollektionJSTOR Complete Journals

KollektionRCN full-text journals@Ovid

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(131)
Mit Volltextzugriff
(129)

Publikationsform

Artikel
(134)

Sprache

Englisch
(134)
Japanisch
(32)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Multicenter Phase II Study of Neoadjuvant Lapatinib and Trastuzumab With Hormonal Therapy and Without Chemotherapy in Patients With Human Epidermal Growth Factor Receptor 2–Overexpressing Breast Cancer: TBCRC 006

STAT3 Signaling Is Activated Preferentially in Tumor‐Initiating Cells in Claudin‐Low Models of Human Breast Cancer

Loss of Phosphatase and Tensin Homolog or Phosphoinositol-3 Kinase Activation and Response to Trastuzumab or Lapatinib in Human Epidermal Growth Factor Receptor 2–Overexpressing Locally Advanced Breast Cancers

Insulin-Like Growth Factor-I Activates Gene Transcription Programs Strongly Associated With Poor Breast Cancer Prognosis

Modernizing Eligibility Criteria for Molecularly Driven Trials

Making Sense of Clinical Trial Data: Is Inverse Probability of Censoring Weighted Analysis the Answer to Crossover Bias?

The HOXB13:IL17BR Expression Index Is a Prognostic Factor in Early-Stage Breast Cancer

A fully Bayesian latent variable model for integrative clustering analysis of multi-type omics data

Analysis of phosphatases in ER-negative breast cancers identifies DUSP4 as a critical regulator of growth and invasion

Cyclopamine inhibition of human breast cancer cell growth independent of Smoothened (Smo)

Neoadjuvant Trastuzumab Induces Apoptosis in Primary Breast Cancers

BRCAPRO Validation, Sensitivity of Genetic Testing of BRCA1/BRCA2, and Prevalence of Other Breast Cancer Susceptibility Genes

Gene expression patterns in formalin-fixed, paraffin-embedded core biopsies predict docetaxel chemosensitivity in breast cancer patients

Identification of Murine Uterine Genes Regulated in a Ligand-Dependent Manner by the Progesterone Receptor

Patterns of Resistance and Incomplete Response to Docetaxel by Gene Expression Profiling in Breast Cancer Patients

Amplification and over-expression of MAP3K3 gene in human breast cancer promotes formation and survival of breast cancer cells

Intrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy

Estrogen and insulin-like growth factor-I (IGF-I) independently down-regulate critical repressors of breast cancer growth

HER2-Enriched Subtype and ERBB2 Expression in HER2-Positive Breast Cancer Treated with Dual HER2 Blockade

Enhancement of Insulin-Like Growth Factor Signaling in Human Breast Cancer: Estrogen Regulation of Insulin Receptor Substrate-1 Expression in Vitro and in Vivo

Association of Surgery With Improved Survival in Stage IV Breast Cancer Patients

Thermal enhancement with optically activated gold nanoshells sensitizes breast cancer stem cells to radiation therapy

Transcriptional Profiling of Mammary Gland Side Population Cells

Hazard rates of recurrence following diagnosis of primary breast cancer

Low PTEN levels and PIK3CA mutations predict resistance to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2 over-expressing breast cancer

Aktive Filter

Suchergebnisse filtern